US 7985581
Multiple RNA polymerase III promoter expression constructs
granted A61KA61K38/00A61P
Quick answer
US patent 7985581 (Multiple RNA polymerase III promoter expression constructs) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 62
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12, A61P43/00